NeuroPace, Inc.
NPCE
$15.96
$0.332.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.52% | 48.02% | 35.88% | -15.13% | 26.17% |
| Total Depreciation and Amortization | 11.04% | 15.74% | 7.98% | 7.43% | 9.22% |
| Total Amortization of Deferred Charges | 38.78% | 28.57% | 48.94% | 1.85% | -37.18% |
| Total Other Non-Cash Items | -12.50% | -8.19% | -0.60% | 13.61% | -16.23% |
| Change in Net Operating Assets | 45.37% | 97.90% | -404.93% | 694.60% | -65.19% |
| Cash from Operations | 21.14% | 110.55% | -12.76% | 46.51% | 0.61% |
| Capital Expenditure | -216.22% | -148.72% | 70.00% | -166.67% | 64.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -216.22% | -104.95% | -102.14% | -105.19% | -101.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | -23.09% | -- | -64.72% | 9,731.07% |
| Repurchase of Common Stock | 99.65% | 4.35% | -50.00% | -141.67% | -7,569.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.79% | -25.12% | -108.11% | -474.85% | 29,216.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.50% | 152.52% | -185.82% | -2,602.60% | 368.56% |